查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018728

臨終關懷市場：按服務類型、護理類型、應用和病患狀況分類－2026-2032年全球市場預測

Hospice Market by Service Type, Care Type, Application, Patient Condition - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，臨終關懷市場價值將達到 1,395.9 億美元，到 2026 年將成長至 1,504 億美元，到 2032 年將達到 2,408.2 億美元，複合年成長率為 8.10%。

主要市場統計數據
基準年 2025 1395.9億美元
預計年份：2026年 1504億美元
預測年份 2032 2408.2億美元
複合年成長率 (%) 8.10%

我們著眼於不斷發展的臨終關懷生態系統，定義了臨床重點、營運韌性、人才動態和政策壓力之間的交集。

臨終關懷行業正處於轉折點，其特徵是人口結構變化、護理偏好轉變以及支付方和提供方面臨的日益成長的財務壓力。近年來，老齡化社會中慢性病和危及生命的疾病盛行率不斷上升，導致人們對富有同情心、多學科的臨終關懷的需求增加，同時也暴露了供給能力和基礎設施方面的系統性限制。

正在重塑臨終關懷服務系統的變革力量包括數位護理的擴展、人力資源系統的重組、供應鏈的韌性以及基於績效的薪酬獎勵。

臨終關懷的格局正在發生變化，需要在臨床、營運和財務等各個領域進行策略調整。科技的普及加速了遠距症狀管理和虛擬看護者支援的發展，促使醫療服務提供者將遠端醫療和數位監測融入傳統的照護計畫中。這些進步改善了農村和醫療資源匱乏地區病患的就醫途徑，同時也改變了資源分配和人員配備模式。

醫療進口關稅的累積壓力促使人們重新評估策略採購、重新設計採購流程，並共同努力降低整個臨終關懷供應鏈的成本。

影響進口醫療設備和用品的關稅政策正對臨終關懷機構及其供應鏈產生多層次的成本和營運影響。累積的關稅壓力推高了某些醫療設備、耗材和生產材料的接收成本，進而影響了居家照護和機構照護的籌資策略。這些壓力波及整個經銷網路，迫使採購方重新評估其供應商合約、庫存緩衝和總體擁有成本 (TCO) 分析。

針對不同服務類型、護理環境、應用場景和不同患者群體，對臨床設計、人員配備模式和供應鏈的特定影響。

細分市場層面的趨勢揭示了不同的需求促進因素和營運挑戰，這需要針對每項服務組合和患者群體採取個人化的方法。根據服務類型，服務範圍涵蓋諮詢服務、醫療用品服務、護理服務和醫生服務，每項服務都有其獨特的人員編制、認證和品質保證要求。諮詢服務著重於心理社會介入和看護者支持框架，而醫療用品服務則需要強大的庫存管理和物流夥伴關係。護理服務需要可擴展的人員配備模式和基於能力的症狀管理培訓，而醫生服務則專注於臨床督導、複雜症狀管理和跨學科協作。

美洲、歐洲、中東和非洲以及亞太地區的區域差異，需要製定針對特定區域的臨床模式、籌資策略和人力資源計畫。

區域多樣性既影響臨終關懷服務的機遇，也帶來營運風險，因此需要製定因地理而異的服務拓展和韌性策略。在美洲，許多地區的人口老化推動了對社區和居家臨終關懷服務的需求，而都市區差距則阻礙了人們獲得專業的安寧療護服務。聯邦和地方各轄區的法律規範和支付方安排差異顯著，影響服務提供者的合約策略、許可要求和跨境夥伴關係。因此，在該地區運作的機構必須優先考慮擴充性遠端醫療能力和人員配備模式，以便靈活適應人口稠密地區和偏遠地區的不同情況。

透過競爭與合作，企業採取各種行動，促進整合、產能投資和綜合護理平台，以加強其在臨終關懷市場的地位。

臨終關懷領域的競爭格局正在重塑，整合、垂直整合和基於能力的差異化成為關注的焦點。領先的機構正在投資建造臨床卓越中心、為安寧療護臨床醫生提供高級培訓，並開發可互通的平台，以實現居家照護和機構護理之間的無縫銜接。供應商生態系統也積極回應，開發捆綁式服務、遠端監控解決方案以及專門針對臨終關懷需求最佳化的物流服務。

確保臨終關懷績效的實用建議，包括採購彈性、員工團隊永續性、數位化、護理路徑重新設計以及支付方與提供者之間的夥伴關係。

領導者應優先採取一系列切實可行的措施，以平衡短期營運韌性與中期策略定位。首先，透過供應商多元化和協商包含價格限制條款和彈性交貨條件的合約條款，最佳化採購流程。其次，透過加強庫存管理和實施基於績效的供應商評估表，確保關鍵醫療用品的持續供應。

概述了調查方法，解釋了相關人員的參與、定性三角測量、基於情境的分析以及支持臨終關懷領域見解的道德保障。

本研究整合了來自醫療服務提供者訪談、供應商評估、監管審查和二手文獻的定性和定量信息，以得出可操作的見解。主要相關人員的參與包括臨床負責人、採購主管和政策顧問，他們提供了關於營運挑戰和創新採納的背景觀點。收集到的資訊與公開的監管指南、臨床實踐標準和可觀察的採購行為進行交叉比對，以檢驗研究主題並識別採納障礙。

統一結論強調，加強臨終關懷需要在採購、數位化能力、人才培養以及與支付方的合作方面採取協調一致的行動。

臨終關懷產業正處於戰略十字路口，人口需求、技術機會、人力資源限制和不斷變化的政策在此交匯。對領導者而言，至關重要的是將洞察轉化為綜合行動。具體而言，這包括增強供應鏈韌性，實施切實可行的數位化工具以擴大臨床服務能力，以及重新設計護理路徑以應對患者病情的複雜性，無論是在家中還是在機構中。同樣重要的是投資於人才培養和保留，因為人仍然是高品質臨終關懷的核心要素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：臨終關懷市場：依服務類型分類

  • 諮詢服務
  • 醫療用品服務
  • 護理服務
  • 醫生服務

第9章：按護理類型分類的臨終關懷市場

  • 持續居家照護
  • 普通住院護理
  • 住院短期照顧
  • 日常居家照護

第10章：臨終關懷市場：依應用領域分類

  • 院內護理
    • 臨終關懷中心
    • 醫院
    • 護理機構
  • 居家照護

第11章：以病人病情分類的臨終關懷市場

  • 癌症患者
  • 心血管疾病
  • 慢性腎臟病
  • 愛滋病毒/愛滋病
  • 神經系統疾病
  • 呼吸系統疾病

第12章 臨終關懷市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：臨終關懷市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 臨終關懷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國臨終關懷市場

第16章：中國臨終關懷市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AccentCare, Inc.
  • Agape Care Group
  • Amedisys, Inc.
  • Amvis Holdings, Inc.
  • BAYADA Home Health Care
  • Care24 Pvt Ltd.
  • Community Hospice & Palliative Care
  • Compassus
  • Dierksen Hospice
  • Elara Caring
  • Enhabit, Inc.
  • Envision Healthcare Holdings, Inc
  • Gateway Hospice & Palliative Care
  • Genesis Healthcare, Inc.
  • Gentiva
  • Heart to Heart Hospice
  • Hope Hospice Inc.
  • Humana Inc.
  • Interim HealthCare Inc
  • Jeevodaya Hospice
  • LHC GROUP, INC.
  • Lifepath Hospice Care Services
  • Option Care Health Inc.
  • Sage Hospice Holdings, LLC
  • St Andrew's Hospice
  • Traditions Health, LLC
  • Trustbridge, Inc
  • VITAS Healthcare by Chemed Corporation
Product Code: MRR-CA17E905E7ED

The Hospice Market was valued at USD 139.59 billion in 2025 and is projected to grow to USD 150.40 billion in 2026, with a CAGR of 8.10%, reaching USD 240.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 139.59 billion
Estimated Year [2026] USD 150.40 billion
Forecast Year [2032] USD 240.82 billion
CAGR (%) 8.10%

A focused orientation to the evolving hospice ecosystem, defining the intersection of clinical priorities, operational resilience, workforce dynamics, and policy pressures

The hospice sector is navigating an inflection point defined by demographic shifts, evolving care preferences, and intensified fiscal pressures across payers and providers. In recent years, the prevalence of chronic, life-limiting conditions among aging populations has increased demand for compassionate, multidisciplinary end-of-life care while simultaneously exposing systemic constraints in workforce capacity and supply infrastructure.

Clinicians and administrators are adapting by reconfiguring care pathways, investing in interoperable technologies, and exploring hybrid service models that blend home-based and facility-based care. At the same time, payers and regulators are revisiting reimbursement frameworks and quality metrics to better reward outcomes that reflect patient-centered goals. These converging forces create both risk and opportunity for stakeholders who can align clinical excellence with operational resilience.

This introduction frames the subsequent analysis by highlighting the need for integrated strategies that address clinical delivery, supply chain integrity, workforce sustainability, and regulatory alignment. Readers will find an evidence-informed synthesis designed to support pragmatic decisions, enabling leaders to prioritize interventions that preserve care quality while strengthening organizational agility.

Transformative forces reshaping hospice delivery including digital care expansion, workforce redesign, supply chain resilience, and outcome-driven reimbursement incentives

The landscape of hospice care is shifting in ways that demand strategic recalibration across clinical, operational, and financial domains. Technological diffusion has accelerated remote symptom management and virtual caregiver support, prompting providers to embed telehealth and digital monitoring within traditional care plans. These advances are improving access for patients in rural and underserved communities while also changing resource allocation and staffing models.

Concurrently, workforce dynamics are exerting sustained pressure: recruitment challenges, burnout, and the need for specialized palliative training are prompting organizations to redesign roles and invest in retention strategies. Policy and payment reforms are increasingly linking reimbursement to patient-reported outcomes and care continuity metrics, which incentivizes integrated care pathways and cross-setting coordination between home-based and facility-based services.

Supply chain resilience has become a strategic imperative after recent global disruptions exposed vulnerabilities in sourcing critical medical supplies and durable equipment. As a result, providers are expanding supplier diversification, nearshoring procurement where feasible, and establishing inventory governance to avoid care interruptions. Taken together, these transformative shifts require leaders to pursue adaptive strategies that balance innovation with rigorous clinical governance and sustainable operational models.

Cumulative tariff-driven pressures on medical imports prompting strategic sourcing shifts, procurement redesign, and collaborative cost-mitigation across hospice supply chains

Tariff policies affecting imported medical equipment and supplies have introduced a layered set of cost and operational implications for hospice providers and their supply chains. Cumulative tariff pressures contribute to higher landed costs for certain devices, disposable supplies, and manufacturing inputs, which in turn affect procurement strategies across both home-based and facility-based care settings. These pressures have propagated through distribution networks, prompting buyers to reassess supplier contracts, inventory buffers, and total cost of ownership analyses.

In response, many health systems and standalone hospice operators have accelerated diversification of sourcing to include domestic manufacturers where feasible and to qualify alternative suppliers in regions not subject to elevated duties. This tactical pivot reduces single-source exposure but often requires investments in validation, staff training, and logistics reconfiguration. Additionally, capital procurement timelines have lengthened as purchasing teams incorporate tariff-adjusted cost scenarios and tariff mitigation clauses within supplier agreements.

Policy uncertainty has also catalyzed strategic conversations at the payer and system level about cost containment and reimbursement alignment. Some providers are layering procurement collaboratives and group purchasing arrangements to regain negotiating leverage, while others are redesigning care pathways to limit reliance on tariff-exposed goods without compromising clinical outcomes. Ultimately, the cumulative effect of tariff dynamics is to accelerate structural change in sourcing, contracting, and inventory governance across the hospice ecosystem.

Segment-specific implications for clinical design, staffing models, and supply chains across service types, care settings, applications, and diverse patient condition cohorts

Segment-level dynamics reveal differentiated demand drivers and operational imperatives that require tailored approaches across service portfolios and patient cohorts. Based on Service Type, the landscape spans counselling services, medical supply services, nursing services, and physician services, each with distinct staffing, credentialing, and quality assurance imperatives. Counselling services emphasize psychosocial interventions and caregiver support frameworks, while medical supply services demand robust inventory controls and logistics partnerships. Nursing services require scalable staffing models and competency-based training for symptom management, and physician services focus on clinical oversight, complex symptom control, and interdisciplinary coordination.

Based on Care Type, providers must align resource intensity with care setting needs across continuous home care, general inpatient care, inpatient respite care, and routine home care. Continuous home care emphasizes intensive nursing and rapid-response capabilities, general inpatient care centers on acute symptom stabilization within licensed facilities, inpatient respite care provides temporary relief for caregivers, and routine home care addresses longitudinal symptom monitoring and routine visits. These care types drive differences in workforce scheduling, documentation protocols, and emergency escalation pathways.

Based on Application, the continuum includes facility-based care and home-based care. Facility-based care subdivides into hospice centers, hospitals, and skilled nursing facilities, each presenting unique regulatory environments, capital demands, and coordination challenges with community providers. Home-based care requires investments in mobile technology, remote monitoring, and caregiver education to ensure safe transitions. Finally, based on Patient Condition, service design must be sensitive to the needs of cancer patients, those with cardiovascular diseases, chronic kidney disease, HIV/AIDS, neurological disorders, and respiratory diseases. Clinical protocols, medication management, and palliative interventions must be adapted to the symptomatic profiles and prognostic trajectories associated with these conditions, while care teams integrate specialty consultations and advance care planning to optimize comfort and dignity.

Regional differentiation across the Americas, Europe Middle East & Africa, and Asia-Pacific that requires tailored clinical models, procurement strategies, and workforce planning

Regional heterogeneity shapes both opportunity and operational risk in hospice delivery, requiring geographically attuned strategies for service expansion and resilience. In the Americas, demographic aging in many jurisdictions is increasing demand for community-based and home-centered hospice services, while urban-rural divides challenge access to specialized palliative care. Regulatory frameworks and payer arrangements vary significantly across federal and subnational jurisdictions, which influences provider contracting strategies, licensure requirements, and cross-border partnerships. Consequently, organizations operating in this region must prioritize scalable telehealth capabilities and workforce deployment models that can flex between densely populated and remote service areas.

Across Europe, Middle East & Africa, diverse health system maturities and financing mechanisms create a mosaic of needs. In higher-income markets, there is growing emphasis on quality metrics, patient-reported outcomes, and integrated care pathways; in emerging markets, basic access to trained palliative clinicians and essential medicines remains a dominant priority. Cultural expectations around end-of-life care also shape family involvement and service design, requiring culturally sensitive engagement strategies and community education initiatives. Meanwhile, public-private collaborations and philanthropic partnerships can play an outsized role in capacity building and training in this region.

The Asia-Pacific region is characterized by rapid demographic transitions, urbanization, and an expanding middle class that is driving demand for both facility-based and home-based hospice services. Workforce constraints are acute in several countries, intensifying the need for task-shifting, telehealth integration, and community health worker training to extend palliative reach. Cross-border supply chains and regional manufacturing hubs influence procurement strategies, and regulatory harmonization efforts offer potential opportunities for scalable service models across multiple jurisdictions. In each region, success depends on aligning clinical models with local payer rules, cultural norms, and supply chain realities while leveraging technology to bridge access gaps.

Competitive and collaborative corporate behaviors driving consolidation, capability investment, and integrated care platforms to strengthen hospice market positioning

Competitive dynamics among organizations operating in the hospice space are being reshaped by consolidation, vertical integration, and a focus on capability-based differentiation. Leading providers are investing in clinical centers of excellence, advanced training for palliative clinicians, and interoperable platforms that enable seamless transitions between home-based and facility-based care. Supplier ecosystems are responding by developing bundled service offerings, remote monitoring solutions, and logistics services that are specifically optimized for end-of-life care needs.

Strategic alliances between payers and providers are also emerging, with some entities piloting alternative payment structures tied to patient experience and continuity of care. These collaborations incentivize investments in care coordination teams, data analytics to track outcomes, and enhanced caregiver support programs. Healthcare technology vendors are differentiating through integrated platforms that combine electronic medical records, telehealth, and remote symptom monitoring, while service organizations enhance capabilities in bereavement counselling and caregiver education to increase both clinical value and brand trust.

Smaller and regional operators compete by emphasizing local community ties, cultural competence, and nimble operational models that can adapt quickly to regulatory or supply chain disruptions. Across the landscape, the ability to demonstrate clinical quality, operational reliability, and cost-effective integration across settings is becoming the key determinant of long-term competitive advantage.

Practical recommendations for procurement resilience, workforce sustainability, digital enablement, care pathway redesign, and payer-provider partnerships to secure hospice performance

Leaders should prioritize a set of actionable measures that balance immediate operational resilience with medium-term strategic positioning. First, optimize procurement by diversifying supplier bases and negotiating contract terms that include tariff mitigation clauses and flexible delivery. Strengthen inventory governance and adopt performance-based supplier scorecards to maintain continuity of critical medical supplies.

Second, invest in workforce sustainability through targeted retention programs, competency-based palliative training, and role redesign that enables efficient task allocation between registered clinicians and ancillary staff. Embed mental health supports and professional development pathways to reduce turnover and enhance care quality. Third, accelerate digital enablement by scaling telehealth for symptom management, deploying remote monitoring where clinically appropriate, and integrating electronic health records to reduce fragmentation across home-based and facility-based care settings. These investments should be paired with clear data governance and interoperability plans.

Fourth, redesign care pathways that align with differentiated segments: calibrate staffing and resource intensity across continuous home care, general inpatient care, inpatient respite, and routine home care to match patient needs and avoid unnecessary escalation. Tailor clinical protocols for major patient condition cohorts, ensuring that disease-specific symptom management and advance care planning are standardized and measurable. Finally, pursue strategic partnerships with payers, manufacturers, and community organizations to pilot value-based arrangements, expand access, and share clinical data that supports outcome-based reimbursement models. Together, these recommendations create a pragmatic roadmap for sustaining high-quality, economical hospice care.

Methodological overview describing stakeholder engagement, qualitative triangulation, scenario-based analysis, and ethical safeguards underpinning the hospice sector insights

This research synthesizes qualitative and quantitative inputs from provider interviews, supplier assessments, regulatory reviews, and secondary literature to derive actionable insights. Primary stakeholder engagement included clinical leaders, procurement executives, and policy advisors who provided contextualized perspectives on operational challenges and innovation adoption. Inputs were triangulated with public regulatory guidance, clinical practice standards, and observable procurement behaviors to validate themes and identify adoption barriers.

Analytical approaches combined thematic content analysis with scenario-based stress testing of supply chain and workforce variables to ensure conclusions remain robust across plausible operational conditions. Careful attention was paid to ethical considerations in data handling, and all primary interviews were conducted under protocols that protect confidentiality and professional anonymity. Methodological limitations are acknowledged where data access constrained granularity, and recommendations are therefore framed to emphasize strategic orientation and operational levers rather than prescriptive metrics.

Integrated conclusion emphasizing the need for coordinated action across procurement, digital capability, workforce development, and payer collaboration to fortify hospice care

The hospice sector stands at a strategic crossroads where demographic demand, technological opportunity, workforce limits, and policy evolution intersect. The imperative for leaders is to convert insight into integrated action: reinforcing supply chain resilience, adopting pragmatic digital tools that extend clinical capacity, and redesigning care pathways to match patient complexity across home-based and facility-based settings. Equally important is the need to invest in workforce development and retention, because the human element remains the core of high-quality end-of-life care.

Organizations that proactively align procurement strategy, clinical governance, and payer engagement will be better positioned to absorb external shocks and deliver consistent, compassionate care. The cumulative picture is one of transformation rather than disruption: those who pursue deliberate, evidence-informed change can create more resilient and patient-centered hospice systems that sustain quality while adapting to economic and policy headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hospice Market, by Service Type

  • 8.1. Counselling Services
  • 8.2. Medical Supply Services
  • 8.3. Nursing Services
  • 8.4. Physician Services

9. Hospice Market, by Care Type

  • 9.1. Continuous Home Care
  • 9.2. General Inpatient Care
  • 9.3. Inpatient Respite Care
  • 9.4. Routine Home Care

10. Hospice Market, by Application

  • 10.1. Facility-based Care
    • 10.1.1. Hospice Center
    • 10.1.2. Hospitals
    • 10.1.3. Skilled Nursing Facility
  • 10.2. Home-based Care

11. Hospice Market, by Patient Condition

  • 11.1. Cancer Patients
  • 11.2. Cardiovascular Diseases
  • 11.3. Chronic Kidney Disease
  • 11.4. HIV/AIDS
  • 11.5. Neurological Disorders
  • 11.6. Respiratory Diseases

12. Hospice Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hospice Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hospice Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Hospice Market

16. China Hospice Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AccentCare, Inc.
  • 17.6. Agape Care Group
  • 17.7. Amedisys, Inc.
  • 17.8. Amvis Holdings, Inc.
  • 17.9. BAYADA Home Health Care
  • 17.10. Care24 Pvt Ltd.
  • 17.11. Community Hospice & Palliative Care
  • 17.12. Compassus
  • 17.13. Dierksen Hospice
  • 17.14. Elara Caring
  • 17.15. Enhabit, Inc.
  • 17.16. Envision Healthcare Holdings, Inc
  • 17.17. Gateway Hospice & Palliative Care
  • 17.18. Genesis Healthcare, Inc.
  • 17.19. Gentiva
  • 17.20. Heart to Heart Hospice
  • 17.21. Hope Hospice Inc.
  • 17.22. Humana Inc.
  • 17.23. Interim HealthCare Inc
  • 17.24. Jeevodaya Hospice
  • 17.25. LHC GROUP, INC.
  • 17.26. Lifepath Hospice Care Services
  • 17.27. Option Care Health Inc.
  • 17.28. Sage Hospice Holdings, LLC
  • 17.29. St Andrew's Hospice
  • 17.30. Traditions Health, LLC
  • 17.31. Trustbridge, Inc
  • 17.32. VITAS Healthcare by Chemed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOSPICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOSPICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOSPICE MARKET SIZE, BY CARE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOSPICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOSPICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOSPICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOSPICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HOSPICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 120. GCC HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GCC HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. GCC HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 138. G7 HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. G7 HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. G7 HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. G7 HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 144. NATO HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NATO HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NATO HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. NATO HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOSPICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2032 (USD MILLION)